News
 
Pharmaceuticals Newsletter - May 21 to May 25, 2012
India Infoline News Service/19:38,May 25, 2012
Piramal Healthcare Limited announced today that Phase I clinical trial data for its investigational new drug candidate P1446A-05 will be presented at the Annual Meeting of the American Society for Clinical Oncology (ASCO) being convened in Chicago from June 1-5, 2012.
list India Infoline Weekly Newsletter - May 25, 2012
list Pfizer recalls Advil bottles from distributor centers
list Teva outlines financial estimates for 2012
list Ranbaxy hires advisers for resolving consent decree with USFDA

Calendar

May-2012
M T W T F S S
21 22 23 24 25 26 27
Economic Events
list Corporate Service Price (YoY)
list Hometrack Housing Survey (MoM)
Results
list No result today
IPO
listNo IPO today
 
Skip Navigation Links.

Bafna Pharmaceuticals net profit rises 33.08% in the December 2011 quarter
Capital Market / 17:19 , Feb 10, 2012

Sales decline 23.19% to Rs 21.07 crore

Net profit of Bafna Pharmaceuticals rose 33.08% to Rs 1.77 crore in the quarter ended December 2011 as against Rs 1.33 crore during the previous quarter ended December 2010. Sales declined 23.19% to Rs 21.07 crore in the quarter ended December 2011 as against Rs 27.43 crore during the previous quarter ended December 2010.

ParticularsQuarter Ended
 Dec. 2011Dec. 2010% Var.
Sales21.0727.43 -23
OPM %25.8211.37 127
PBDT4.222.05 106
PBT1.371.46 -6
NP1.771.33 33

 



Rate This Article Rate 1 Rate 2 Rate 3 Rate 4 Rate 5